No Carolina / NY / Florida
Ph: 561.316.3330

No Carolina | NY | Florida

Truliant Porous Knee System Launches Reports Exactech

Editor: What To Know

  • It enhances the award-winning knee system and is designed for strength and stability for patients, and efficiency for surgeons and staff in the operating room.
  • The Truliant Porous Knee enhances the company's advanced material science platform with a solution that is designed to mimic the trabecular nature of cancellous bone with optimal pore size and porosity.
  • Exactech, a developer and producer of innovative implants, instrumentation and smart technologies for joint replacement surgery, today announced the expansion of its Truliant® Total Knee System with a new porous-coated implant option.

Truliant Porous Knee System Full Launch

Exactech, a developer and producer of innovative implants, instrumentation and smart technologies for joint replacement surgery, today announced the expansion of its Truliant® Total Knee System with a new porous-coated implant option.

Full launch of the Truliant Porous Knee System is welcome news for surgeons who are interested in a non-cemented approach. It enhances the award-winning knee system and is designed for strength and stability for patients, and efficiency for surgeons and staff in the operating room.

“Exactech’s Truliant Porous Knee system embodies state-of-the-art technology, manufacturing and instrumentation allowing surgeons to confidently address our ever-changing patient populations,” said James B. Duke, MD, of the Orthopaedic Institute in Ocala, Fla. “I believe surgeons looking to maximize longevity, performance and durability in their implants will want to utilize Exactech’s Truliant Porous Knee technology to best handle surgical challenges and patient expectations.”

The Truliant Porous Knee enhances the company’s advanced material science platform with a solution that is designed to mimic the trabecular nature of cancellous bone with optimal pore size and porosity. The porous structures integrated into the implant design are designed to facilitate a durable bonding surface to allow for immediate and long-term biological fixation. Peripheral pegs allow for stable initial fixation while the channeled keel is designed with flutes to increase bony-implant engagement for increased stability and resistance to micromotion.

The Truliant Porous Knee seamlessly integrates with the system’s ergonomically designed mechanical instrumentation and the ExactechGPS® TKA Pro application for a guided, personalized experience. The Truliant Total Knee System includes cruciate-retaining and posterior-stabilized implants, as well as constrained insert options, and integrates with a fully comprehensive revision system that offers metaphyseal cones, stems, tibial augments and offsets.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Recent News

VeraClinic: Pioneering Personal Transformation Through Hair Transplantation and Cosmetic Surgery in Turkey

As a testament to Turkey's legacy in the world of aesthetic medicine, VeraClinic invites you to discover the transformative power of our hair transplantation and cosmetic surgery services.

CV Societies Propel Plans Forward for a New Board of Cardiovascular Medicine

“The open comment period is the time for cardiovascular physicians, allies in other medical specialties, patients, and others to make their voices heard on why an independent CV Board is the best path for cardiologists to stay up-to-date on best practices and evidence-based care, ensuring patients receive the best possible care,” said Jeffrey Kuvin, MD, president of the proposed Board’s new Board of Directors. “The field of cardiovascular medicine has evolved dramatically over the past few decades; now is the right time to develop an independent cardiovascular Board.”

Hyundai Bioscience Announces Clinical Development Plan for Niclosamide-based Metabolic Anticancer Drug Targeting P53 Mutation Cancer

Sang-ki Oh, CEO of Hyundai Bioscience, stated, "Niclosamide-based metabolic anticancer drug candidate will be the first P53-targeting anticancer treatment that selectively kills p53 mutated cancer cells," and added, "Through our subsidiary ADM Korea, we plan to conduct clinical trials targeting cancer patients with intractable cancer caused by p53 mutations, which will be the first step of clinical development on niclosamide-based anticancer agent pipeline."
Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

About Medical Device News Magazine

About Medical Device News Magazine. A digital publication founded in 2008 located in the United States. The publication is one of the industry’s leading sources of medical device and biotech industry updates. Medical Device News Magazine is easily accessible 24/7/365 and is a fast 1, 2, 3 easy read! Our purpose is...

By using this website you agree to accept Medical Device News Magazine Privacy Policy